We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

688521:SSEVeriSilicon Microelectronics (Shanghai) Co., Ltd. Class A Analysis

Data as of 2026-06-17 - not real-time

CN¥257.46

Latest Price

8/10Risk

Risk Level: High

Executive Summary

VeriSilicon is trading at CNY 257.46, comfortably above its 20‑day (245.15) and 50‑day (250.02) SMAs and well above the 200‑day SMA (195.71), indicating a short‑term bullish bias. The MACD histogram is positive (1.29) and the MACD line sits above its signal line, while the RSI is at a neutral 54.6, suggesting limited upside momentum but no immediate overbought warning. However, the stock’s 30‑day volatility is extreme at 84.6%, the volume trend is decreasing, and the maximum historical drawdown sits near 40%, flagging substantial price instability.
Fundamentally, the company shows 14.5% revenue growth and a 33% gross margin, yet it is deeply loss‑making with a –34% operating margin, –18% profit margin, negative EBITDA, and a forward P/E of 1,401. The balance sheet is strained (debt‑to‑equity 57.7%) and the valuation multiples are sky‑high (P/B 43x, price‑to‑sales 37.6x). The market sentiment index reads “Extreme Greed,” but the underlying financials suggest the price may be disconnected from earnings reality.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Price is above key moving averages but valuation multiples are extreme
  • Negative earnings and high forward P/E
  • Elevated volatility and decreasing volume

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Revenue growth of 14.5% and strong gross margin
  • Continued operating losses and high debt load
  • Sector tailwinds in custom silicon and AI/IoT demand

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Potential strategic shift toward profitable IP licensing
  • Long‑term secular demand for semiconductor customization
  • Need for financial turnaround to justify current price levels

Key Metrics & Analysis

Financial Health

Revenue Growth114.50%
Profit Margin-18.02%
P/E Ratio1401.0
ROE-25.58%
ROA-6.25%
Debt/Equity57.70
P/B Ratio43.0
Op. Cash FlowCN¥-310320032
Free Cash FlowCN¥-571350912
Industry P/E37.0

Technical Analysis

TrendNeutral
RSI54.6
SupportCN¥208.00
ResistanceCN¥303.55
MA 20CN¥245.15
MA 50CN¥250.02
MA 200CN¥195.71
MACDBullish
VolumeDecreasing
Fear & Greed Index88.5

Valuation

GradeOvervalued
TypeGrowth

Risk Assessment

Beta0.89
Volatility84.61%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.